Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility

Abstract

Comparison of citrate- (without anticoagulation) and acetate-based (with anticoagulation) dialysis solution from the view of short-term safety, efficacy and biocompatibility in patients from long-term hemodialysis program. Clinical study.

Keywords

• adequacy
• hemodiafiltration
• citrate
• heparin free
• thrombogenicity